(1)
Mo, Y.; Kang, M.; Xue, F.; Xu, S.; Shi, J. Effectiveness and Safety of Anlotinib With or Without S-1 in the Treatment of Patients With Advanced Hepatocellular Carcinoma in Chinese Population: A Prospective, Phase 2 Study. Radiol Oncol 2023, 57, 405-410.